RxDoctor Payments Data

Jillian Frieder, MD

Dermatology · Boca Raton, FLNPI 1023490018

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,666 of the $12,320 with a category attached, or 62.2%. 27 manufacturers reported payments, led by Sun Pharmaceutical Industries Inc. at 32.2% of the total. Reporting peaked in 2023 at $3,959 and has fallen 63.2% since, to $1,456 in 2025.

$12,320in general payments, 2019–2025

Across 195 payments — averaging $63.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sun Pharmaceutical Industries Inc.$4K
  • UCB, Inc.$2K
  • AbbVie$2K
  • Amgen$964
  • Pfizer$837
  • Regeneron Healthcare Solutions, Inc.$494
  • plus $2K from 21 others
$8,500in research payments, 2019–2025

Across 2 payments — averaging $4250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$9K

What the payments were for

  • Consulting fees$4,42336%
  • Travel & lodging$220%
  • Food & beverage$7,66662%
  • Education$2102%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,320 in reported general payments places this provider in the 80th percentile of 1,147 dermatology providers in Florida.

See all dermatology providers in Florida →

Medicare billing

Part B allowed, 2024
$1,370,075
Medicare patients
839
Services billed
11,499

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate177$5,885
Fluorouracil81$5,477
Ketoconazole99$1,599
Doxycycline Monohydrate96$1,257
Tretinoin14$1,112
Triamcinolone Acetonide105$1,050
Mupirocin115$843
Clindamycin Phosphate18$609
Metronidazole15$550
Minoxidil46$515
Betamethasone Dipropionate14$413
Mometasone Furoate17$356
ValacyclovirValacyclovir Hcl23$228
Hydrocortisone46$204
Nystatin13$172

Paid to pharmacies, not to this prescriber.

Other dermatology in Boca Raton

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →